The BNP shift also resulted in performance decreases for neurodevelopmental disorders (Delta AUROCF01-F99 [SD], −0.23 [0.04]; Delta AUPRCF01-F99 [SD], −0.19 [0.04]) and nervous system diseases (Delta AUROCG00-G99 [SD], −0.26 [0.04]; Delta AUPRCG00-G99 [SD], −0.21 [0.11]). Here, NPPB is linked to nervous system disorder.